Vol 6, No 1 (2017)
Review article
Published online: 2017-06-20

open access

Page views 1013
Article views/downloads 1163
Get Citation

Connect on Social Media

Connect on Social Media

The role of nuts consumption in the primary and secondary prevention of type 2 diabetes

Agata Klementyna Stróżyk1, Lucyna Pachocka2
Clin Diabetol 2017;6(1):26-33.

Abstract

Type 2 diabetes (DMT2) constitutes approximately 90% of all diabetes cases worldwide and its main feature is chronic hyperglycaemia, which may lead to endothelium dysfunction, atherosclerosis, hypertension, microangiopathy, nephropathy, retinopathy and strokes. Therapy of patients with type 2 diabetes, despite the control of glycaemia, should encompass surveillance of lipid profile, blood pressure and body mass as factors increasing the risk of cardiovascular diseases. The aim of this study was to indicate the association of the consumption of nuts with lower risk of DMT2 and its complication prevention. It was established that the nuts have a positive impact on postprandial glycaemia decrease, insulin sensitivity improvement, ideal body mass maintenance (or its reduction among overweight people) and blood pressure control. As has been shown, implementation of nuts into DMT2 patients’ diet may reinforce the efficacy of the treatment outcomes.

Article available in PDF format

View PDF Download PDF file

References

  1. Global report on diabetes 2016. Geneva: World Health Organization; 2016. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf (03 October 2016).
  2. International Diabetes Federation. Diabetes Atlas – Seventh edition 2015 [online]. Brussels: International Diabetes Federation 2015. http://www.diabetesatlas.org/ (03 October 2016).
  3. Langley-Evans S, Grzymisławski M. Żywienie. Wpływ na zdrowie człowieka. 1st ed. PZWL Jarosz M (ed ), Warszawa 2013.
  4. Polskie Towarzystwo Diabetologiczne. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2016. Diabetologia kliniczna. 2016; 5(supl. A): 1–A84.
  5. Cichocka A. Cukrzyca typu 2. Cz. I. Epidemia naszych czasów. Przemysł spożywczy 2013: 38–40.
  6. USDA. Natio Nutrient Database for Standard Reference Release 28. https://ndb.nal.usda.gov/ndb/ (08 September 2016).
  7. Bewley JD, Black M, Halmer P. The Encyklopedia of Seeds: Science, Technology and Uses. United Kingdom: CABI 2006. http://books.google.pl/books/about/The_Encyclopedia_of_Seeds.html?id=aE414KuXu4gC&redir_esc=y (04 October 2016).
  8. Wierusz-Wysocka B, Araszkiewicz A, Schlaffke J. Końcowe produkty glikacji – nowy biomarker cukrzycy i jej powikłań? Diabetologia Kliniczna. 2013; 2: 96–103.
  9. Brandt A, Zorena K, Myśliwiec M. Końcowe produkty glikacji – źródło pochodzenia a rozwój powikłań cukrzycowych. Diabetologia praktyczna. 2008; 9: 12–17.
  10. Warwas M, Piwowar A, Kopiec G. Zaawansowane produkty glikacji (AGE) w organizmie – powstawanie, losy, interakcja z receptorami i jej następstwa. Farmakologia Polska. 2010; 66: 585–590.
  11. American Diabetes Association. Standards of medical care in diabetes – 2016. Diabetes Care. 2016; 39(Suppl 1): 1–112.
  12. International Diabetes Federation. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation 2012. https://www.idf.org/sites/default/files/IDF%20T2DM%20Guideline.pdf (03 October 2016).
  13. Kendall CWC, Esfahani A, Josse AR, et al. The glycemic effect of nut-enriched meals in healthy and diabetic subjects. Nutr Metab Cardiovasc Dis. 2011; 21 Suppl 1: S34–S39.
  14. Blanco Mejia S, Kendall CWC, Viguiliouk E, et al. Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2014; 4(7): e004660.
  15. Kendall CWC, Josse AR, Esfahani A, et al. The impact of pistachio intake alone or in combination with high-carbohydrate foods on post-prandial glycemia. Eur J Clin Nutr. 2011; 65(6): 696–702.
  16. Casas-Agustench P. Bullo´ M, Salas-Salvado´ J. Nuts, inflammation and insulin resistance. Asia Pac J Clin Nutr. 2010; 19: 124–130.
  17. Wien M, Bleich D, Raghuwanshi M, et al. Almond consumption and cardiovascular risk factors in adults with prediabetes. J Am Coll Nutr. 2010; 29(3): 189–197.
  18. Adamsson V, Reumark A, Fredriksson IB, et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J Intern Med. 2011; 269(2): 150–159.
  19. Barbour JA, Howe PR, Buckley JD, et al. Nut consumption for vascular health and cognitive function. Nutr Res Rev. 2014; 27(1): 131–158.
  20. Salas-Salvadó J, Bulló M, Babio N, et al. PREDIMED Study Investigators. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011; 34(1): 14–19.
  21. Jiang R. Nut and Peanut Butter Consumption and Risk of Type 2 Diabetes in Women. JAMA. 2002; 288(20): 2554.
  22. Kochar J, Gaziano JM, Djoussé L. Nut consumption and risk of type 2 diabetes in Physicians’ Health Study. Eur J Clin Nutr. 2010; 64: 75–79.
  23. Murie-Fernandez M, Irimia P, Toledo E, et al. PREDIMED Investigators. Carotid intima-media thickness changes with Mediterranean diet: a randomized trial (PREDIMED-Navarra). Atherosclerosis. 2011; 219(1): 158–162.
  24. Pan An, Sun Qi, Manson JE, et al. Walnut consumption is associated with lower risk of type 2 diabetes in women. J Nutr. 2013; 143(4): 512–518.
  25. Tan SY, Mattes RD. Appetitive, dietary and health effects of almonds consumed with meals or as snacks: a randomized, controlled trial. Eur J Clin Nutr. 2013; 67(11): 1205–1214.
  26. Dodevska MS, Sobajic SS, Djordjevic PB, et al. Effects of total fibre or resistant starch-rich diets within lifestyle intervention in obese prediabetic adults. Eur J Nutr. 2016; 55(1): 127–137.
  27. Biskupski A, Waligórski S, Kowalik B, et al. Glycated hemoglobin HbA1c - a new risk marker for the outcome of cardiac surgery? Kardiochir Torakochirurgia Pol. 2014; 11(1): 7–11.
  28. Jenkins DJA, Kendall CWC, Banach MS, et al. Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care. 2011; 34(8): 1706–1711.
  29. Viguiliouk E, Kendall CW, Blanco Mejia S, et al. Effect of tree nuts on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled dietary trials. PLoS One. 2014; 9(7): e103376.
  30. Ma L, Wang F, Guo W, et al. Nut consumption and the risk of coronary artery disease: a dose-response meta-analysis of 13 prospective studies. Thromb Res. 2014; 134(4): 790–794.
  31. Zhou D, Yu H, He F, et al. Nut consumption in relation to cardiovascular disease risk and type 2 diabetes: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2014; 100(1): 270–277.
  32. Li TY, Brennan AM, Wedick NM, et al. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr. 2009; 139(7): 1333–1338.
  33. Ma Y, Njike VY, Millet J, et al. Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care. 2010; 33(2): 227–232.
  34. Al-Amoudi NS, Abu Araki HA. Evaluation of vegetable and fish oils diets for the amelioration of diabetes side effects. J Diabetes Metab Disord. 2013; 12(1): 13.
  35. Li SC, Liu YH, Liu JF, et al. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2011; 60(4): 474–479.
  36. Sabaté J, Wien M. Consumption of Nuts in the Prevention of Cardiovascular Disease. Current Nutrition Reports. 2013; 2(4): 258–266.
  37. Kris-Etherton PM, Hu FB, Ros E, et al. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008; 138(9): 1746S–1751S.
  38. Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006; 96 Suppl 2: S68–S78.
  39. Sabaté J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010; 170(9): 821–827.
  40. Alexiadou K, Katsilambros N. Nuts: anti-atherogenic food? Eur J Intern Med. 2011; 22(2): 141–146.
  41. Flores-Mateo G, Rojas-Rueda D, Basora J, et al. Nut intake and adiposity: meta-analysis of clinical trials. Am J Clin Nutr. 2013; 97(6): 1346–1355.
  42. Tey SL, Gray AR, Chisholm AW, et al. The dose of hazelnuts influences acceptance and diet quality but not inflammatory markers and body composition in overweight and obese individuals. J Nutr. 2013; 143(8): 1254–1262.
  43. Casas-Agustench P, López-Uriarte P, Bulló M, et al. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2011; 21(2): 126–135.
  44. Jaceldo-Siegl K, Haddad E, Oda K, et al. Tree nuts are inversely associated with metabolic syndrome and obesity: the Adventist health study-2. PLoS One. 2014; 9(1): e85133.
  45. Cesarettin A, Fereidoon S. Tree Nuts: Composition, Phytochemicals, and Health Effects: An Overview. In:, Fereidoon S (ed.). Tree Nuts: composition, phytochemicals, and health effects. Boca Raton: CRC Press Taylor & Francis Group 2009.
  46. Lima EA, Silveira LS, Masi LN, et al. Macadamia oil supplementation attenuates inflammation and adipocyte hypertrophy in obese mice. Mediators Inflamm. 2014; 2014: 870634.
  47. Park S, Lim Y, Shin S, et al. Impact of Korean pine nut oil on weight gain and immune responses in high-fat diet-induced obese mice. Nutr Res Pract. 2013; 7(5): 352–358.
  48. Tatoń J, Czech A, Bernas M. Histofizjologiczna charakterystyka tkanki tłuszczowej: rozrost i przerost tkanki tłuszczowej w otyłości. In: Tatoń J, Czech A, Bernas M. ed. Otyłość. Zespół metaboliczny. Otyłość Zespół metaboliczny Warszawa, Warszawa 2006: PZWL.
  49. Foster GD, Shantz KL, Vander Veur SS, et al. A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity. Am J Clin Nutr. 2012; 96(2): 249–254.
  50. Gulati S, Misra A, Pandey RM, et al. Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial. Nutrition. 2014; 30(2): 192–197.
  51. St-Onge MP. Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am J Clin Nutr. 2005; 81(1): 7–15.
  52. Mattes RD, Kris-Etherton PM, Foster GD. Impact of peanuts and tree nuts on body weight and healthy weight loss in adults. J Nutr. 2008; 138(9): 1741S–1745S.
  53. Rajaram S, Sabaté J. Nuts, body weight and insulin resistance. Br J Nutr. 2006; 96 Suppl 2: S79–S86.
  54. Cassady BA, Hollis JH, Fulford AD, et al. Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response. Am J Clin Nutr. 2009; 89(3): 794–800.
  55. Vadivel V, Kunyanga CN, Biesalski HK, et al. Health benefits of nut consumption with special reference to body weight control. Nutrition 20 The relationship between nut consumption and blood pressure in an Iranian adult population: Isfahan Healthy Heart Program. Nutr Metab Cardiovasc Dis. 2013; 23: 929–936.
  56. Ibarrola-Jurado N, Bulló M, Guasch-Ferré M, et al. Cross-Sectional Assessment of Nut Consumption and Obesity, Metabolic Syndrome and Other Cardiometabolic Risk Factors: The PREDIMED Study. PLoS ONE. 2013; 8(2): e57367.
  57. Djoussé L, Rudich T, Gaziano JM. Nut consumption and risk of hypertension in US male physicians. Clin Nutr. 2009; 28(1): 10–14.